Skip to content
Explore the latest in technology, digital trends, and insig…

TikTok Content Creators Fueling Parallel Market for Unlicensed Weight-Loss Drug

A shadow economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users injecting products of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and customer regulations, risking fines, legal action or prison.

Service Reaction and Material Removal

According to TikTok, the platform has taken down violative material and banned related hashtags and query recommendations. The company said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at residence.

After minutes of joining one community, a vendor posted WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Within these groups, messages display black plastic packages with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Even if the science behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly significant medical dangers”.

About the author

Teresa Maddox

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on society.

Tech Insights Hub

Type to search articles.